Introduction

Seminars in Oncology

Volumn 35, Issue SUPPL 3, 2008, Pages

  Horwitz, Susan Band ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; PACLITAXEL; TUBULIN; VINBLASTINE; VINCRISTINE; VINFLUNINE;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BLADDER TUMOR; BREAST CANCER; CANCER RESEARCH; CELL ACTIVITY; CELL CYCLE PROGRESSION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HUMAN; KAPOSI SARCOMA; LUNG NON SMALL CELL CANCER; MICROTUBULE; NEOPLASM; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SOLID TUMOR; TUMOR RESISTANCE;

EID: 44449175045     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.01.005     Document Type: Editorial

References (20)

1. Orr G.A., Verdier-Pinard P., McDaid H.M., and Horwitz S.B. Mechanisms of Taxol resistance related to microtubules. Oncogene 22 (2003) 7280-7295
2. Nogales E. Structural insight into microtubule function. Annu Rev Biophys Biomol Struct 30 (2001) 397-420
3. Wilson L., Jordan M.A., Morse A., and Margolis R. Interactions of vinblastine with steady-state microtubules in vitro. J Mol Biol 159 (1982) 125-149
4. Jordan M.A., and Wilson L. Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrations. Biochemistry 29 (1990) 2730-2739
5. Desai A., and Mitchison T.J. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 13 (1997) 83-117
6. Jordan M.A., Toso R.J., Thrower D., and Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A 90 (1993) 9552-9556
7. Derry W.B., Wilson L., and Jordan M.A. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34 (1995) 2203-2211
8. Correia J.J., and Lobert S. Physiochemical aspects of tubulin-interacting antimitotic drugs. Curr Pharm Des 7 (2001) 1213-1228
9. Noble R.L., Beer C.T., and Cutts J.H. Further biological activities of vincaleukoblastine-an alkaloid isolated from Vinca rosea (L.). Biochem Pharmacol 1 (1958) 347-357
10. Svoboda G.H. Alkaloids of Vinca rosea Linn. IX. Extraction and characterisation of leurosidine and leucocristine. Lloyda 24 (1961) 173-178
11. Wani M.C., Taylor H.L., Wall M.E., et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93 (1971) 2325-2327
12. Horwitz S.B., Cohen D., Rao S., et al. Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr 15 (1993) 55-61
13. Burkhart C.A., Kavallaris M., and Horwitz S.B. The role of beta-tubulin isotypes in resistance to antimitotic drugs. Biochim Biophys Acta 1471 (2001) O1-O9
14. Kavallaris M., Verrills N.M., and Hill B.T. Anticancer therapy with novel tubulin-interacting drugs. Drug Resist Updat 4 (2001) 392-401
15. Fahy J., Duflos A., Ribet J.P., et al. Vinca alkaloids in superacidic media: a method for creating a new family of antitumor derivatives. J Am Chem Soc 119 (1997) 8576-8577
16. Kruczynski A., Colpaert F., Tarayre J.P., et al. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Cancer Chemother Pharmacol 41 (1998) 437-447
17. Hill B.T., Fiebig H.H., Waud W.R., et al. Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts. Eur J Cancer 35 (1999) 512-520
18. Lobert S., Ingram J.W., Hill B.T., et al. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity. Mol Pharmacol 53 (1998) 908-915
19. Etievant C., Barret J.M., Kruczynski A., et al. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. Invest New Drugs 16 (1998) 3-17
20. Etievant C., Kruczynski A., Barret J.M., et al. Markedly diminished drug resistance-inducing properties of vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro. Cancer Chemother Pharmacol 48 (2001) 62-70